anti-Thomsen-Friedenreich antigen theranostic monoclonal antibody (For-Robin)

N/A

Report date: 2025/03/20 15:09:14

Base Information

Drug Nameanti-Thomsen-Friedenreich antigen theranostic monoclonal antibody (For-Robin)
Drug Alias NamehJAA-F11 based theranostic (For Robin)
ClassificationDiagnostic agent (In vivo)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMetastasis inhibitors
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFor-Robin Inc
China Registration ClassN/A

Develop Information

Active CompaniesFor-Robin Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A